1 Study Coverage 1.1 C-MET / HGF Inhibitors Product Introduction 1.2 Market Segments 1.3 Key C-MET / HGF Inhibitors Manufacturers Covered: Ranking by Revenue 1.4 Market by Type 1.4.1 Global C-MET / HGF Inhibitors Market Size Growth Rate by Type 1.4.2 C-Met Biologic Inhibitors 1.4.3 Small Molecule C-Met Inhibitors 1.4.4 HGF Antagonist Antibodies 1.4.5 C-Met Antagonist Antibodies(MetMAb) 1.4.6 HGF Kringle Variant Antagonists 1.5 Market by Application 1.5.1 Global C-MET / HGF Inhibitors Market Size Growth Rate by Application 1.5.2 Hospital Pharmacies 1.5.3 Retail Pharmacies 1.5.4 Drug Stores 1.5.5 Online Sales 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global C-MET / HGF Inhibitors Market Size, Estimates and Forecasts 2.1.1 Global C-MET / HGF Inhibitors Revenue 2015-2026 2.1.2 Global C-MET / HGF Inhibitors Sales 2015-2026 2.2 Global C-MET / HGF Inhibitors, Market Size by Producing Regions: 2015 VS 2020 VS 2026 2.3 C-MET / HGF Inhibitors Historical Market Size by Region (2015-2020) 2.3.1 Global C-MET / HGF Inhibitors Retrospective Market Scenario in Sales by Region: 2015-2020 2.3.2 Global C-MET / HGF Inhibitors Retrospective Market Scenario in Revenue by Region: 2015-2020 2.4 C-MET / HGF Inhibitors Market Estimates and Projections by Region (2021-2026) 2.4.1 Global C-MET / HGF Inhibitors Sales Forecast by Region (2021-2026) 2.4.2 Global C-MET / HGF Inhibitors Revenue Forecast by Region (2021-2026) 3 Global C-MET / HGF Inhibitors Competitor Landscape by Players 3.1 Global Top C-MET / HGF Inhibitors Sales by Manufacturers 3.1.1 Global C-MET / HGF Inhibitors Sales by Manufacturers (2015-2020) 3.1.2 Global C-MET / HGF Inhibitors Sales Market Share by Manufacturers (2015-2020) 3.2 Global C-MET / HGF Inhibitors Manufacturers by Revenue 3.2.1 Global C-MET / HGF Inhibitors Revenue by Manufacturers (2015-2020) 3.2.2 Global C-MET / HGF Inhibitors Revenue Share by Manufacturers (2015-2020) 3.2.3 Global C-MET / HGF Inhibitors Market Concentration Ratio (CR5 and HHI) (2015-2020) 3.2.4 Global Top 10 and Top 5 Companies by C-MET / HGF Inhibitors Revenue in 2019 3.2.5 Global C-MET / HGF Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global C-MET / HGF Inhibitors Price by Manufacturers 3.4 Global C-MET / HGF Inhibitors Manufacturing Base Distribution, Product Types 3.4.1 C-MET / HGF Inhibitors Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers C-MET / HGF Inhibitors Product Type 3.4.3 Date of International Manufacturers Enter into C-MET / HGF Inhibitors Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Market Size by Type (2015-2026) 4.1 Global C-MET / HGF Inhibitors Market Size by Type (2015-2020) 4.1.1 Global C-MET / HGF Inhibitors Sales by Type (2015-2020) 4.1.2 Global C-MET / HGF Inhibitors Revenue by Type (2015-2020) 4.1.3 C-MET / HGF Inhibitors Average Selling Price (ASP) by Type (2015-2026) 4.2 Global C-MET / HGF Inhibitors Market Size Forecast by Type (2021-2026) 4.2.1 Global C-MET / HGF Inhibitors Sales Forecast by Type (2021-2026) 4.2.2 Global C-MET / HGF Inhibitors Revenue Forecast by Type (2021-2026) 4.2.3 C-MET / HGF Inhibitors Average Selling Price (ASP) Forecast by Type (2021-2026) 4.3 Global C-MET / HGF Inhibitors Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Market Size by Application (2015-2026) 5.1 Global C-MET / HGF Inhibitors Market Size by Application (2015-2020) 5.1.1 Global C-MET / HGF Inhibitors Sales by Application (2015-2020) 5.1.2 Global C-MET / HGF Inhibitors Revenue by Application (2015-2020) 5.1.3 C-MET / HGF Inhibitors Price by Application (2015-2020) 5.2 C-MET / HGF Inhibitors Market Size Forecast by Application (2021-2026) 5.2.1 Global C-MET / HGF Inhibitors Sales Forecast by Application (2021-2026) 5.2.2 Global C-MET / HGF Inhibitors Revenue Forecast by Application (2021-2026) 5.2.3 Global C-MET / HGF Inhibitors Price Forecast by Application (2021-2026) 6 United States by Players, Type and Application 6.1 United States C-MET / HGF Inhibitors Market Size YoY Growth 2015-2026 6.1.1 United States C-MET / HGF Inhibitors Sales YoY Growth 2015-2026 6.1.2 United States C-MET / HGF Inhibitors Revenue YoY Growth 2015-2026 6.1.3 United States C-MET / HGF Inhibitors Market Share in Global Market 2015-2026 6.2 United States C-MET / HGF Inhibitors Market Size by Players (International and Local Players) 6.2.1 United States Top C-MET / HGF Inhibitors Players by Sales (2015-2020) 6.2.2 United States Top C-MET / HGF Inhibitors Players by Revenue (2015-2020) 6.3 United States C-MET / HGF Inhibitors Historic Market Review by Type (2015-2020) 6.3.1 United States C-MET / HGF Inhibitors Sales Market Share by Type (2015-2020) 6.3.2 United States C-MET / HGF Inhibitors Revenue Market Share by Type (2015-2020) 6.3.3 United States C-MET / HGF Inhibitors Price by Type (2015-2020) 6.4 United States C-MET / HGF Inhibitors Market Estimates and Forecasts by Type (2021-2026) 6.4.1 United States C-MET / HGF Inhibitors Sales Forecast by Type (2021-2026) 6.4.2 United States C-MET / HGF Inhibitors Revenue Forecast by Type (2021-2026) 6.4.3 United States C-MET / HGF Inhibitors Price Forecast by Type (2021-2026) 6.5 United States C-MET / HGF Inhibitors Historic Market Review by Application (2015-2020) 6.5.1 United States C-MET / HGF Inhibitors Sales Market Share by Application (2015-2020) 6.5.2 United States C-MET / HGF Inhibitors Revenue Market Share by Application (2015-2020) 6.5.3 United States C-MET / HGF Inhibitors Price by Application (2015-2020) 6.6 United States C-MET / HGF Inhibitors Market Estimates and Forecasts by Application (2021-2026) 6.6.1 United States C-MET / HGF Inhibitors Sales Forecast by Application (2021-2026) 6.6.2 United States C-MET / HGF Inhibitors Revenue Forecast by Application (2021-2026) 6.6.3 United States C-MET / HGF Inhibitors Price Forecast by Application (2021-2026) 7 North America 7.1 North America C-MET / HGF Inhibitors Market Size YoY Growth 2015-2026 7.2 North America C-MET / HGF Inhibitors Market Facts & Figures by Country 7.2.1 North America C-MET / HGF Inhibitors Sales by Country (2015-2020) 7.2.2 North America C-MET / HGF Inhibitors Revenue by Country (2015-2020) 7.2.3 U.S. 7.2.4 Canada 8 Europe 8.1 Europe C-MET / HGF Inhibitors Market Size YoY Growth 2015-2026 8.2 Europe C-MET / HGF Inhibitors Market Facts & Figures by Country 8.2.1 Europe C-MET / HGF Inhibitors Sales by Country 8.2.2 Europe C-MET / HGF Inhibitors Revenue by Country 8.2.3 Germany 8.2.4 France 8.2.5 U.K. 8.2.6 Italy 8.2.7 Russia 9 Asia Pacific 9.1 Asia Pacific C-MET / HGF Inhibitors Market Size YoY Growth 2015-2026 9.2 Asia Pacific C-MET / HGF Inhibitors Market Facts & Figures by Country 9.2.1 Asia Pacific C-MET / HGF Inhibitors Sales by Region (2015-2020) 9.2.2 Asia Pacific C-MET / HGF Inhibitors Revenue by Region 9.2.3 China 9.2.4 Japan 9.2.5 South Korea 9.2.6 India 9.2.7 Australia 9.2.8 Taiwan 9.2.9 Indonesia 9.2.10 Thailand 9.2.11 Malaysia 9.2.12 Philippines 9.2.13 Vietnam 10 Latin America 10.1 Latin America C-MET / HGF Inhibitors Market Size YoY Growth 2015-2026 10.2 Latin America C-MET / HGF Inhibitors Market Facts & Figures by Country 10.2.1 Latin America C-MET / HGF Inhibitors Sales by Country 10.2.2 Latin America C-MET / HGF Inhibitors Revenue by Country 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa C-MET / HGF Inhibitors Market Size YoY Growth 2015-2026 11.2 Middle East and Africa C-MET / HGF Inhibitors Market Facts & Figures by Country 11.2.1 Middle East and Africa C-MET / HGF Inhibitors Sales by Country 11.2.2 Middle East and Africa C-MET / HGF Inhibitors Revenue by Country 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 U.A.E 12 Company Profiles 12.1 Abxign 12.1.1 Abxign Corporation Information 12.1.2 Abxign Description and Business Overview 12.1.3 Abxign Sales, Revenue and Gross Margin (2015-2020) 12.1.4 Abxign C-MET / HGF Inhibitors Products Offered 12.1.5 Abxign Recent Development 12.2 Abbott Laboratories 12.2.1 Abbott Laboratories Corporation Information 12.2.2 Abbott Laboratories Description and Business Overview 12.2.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020) 12.2.4 Abbott Laboratories C-MET / HGF Inhibitors Products Offered 12.2.5 Abbott Laboratories Recent Development 12.3 Amgen 12.3.1 Amgen Corporation Information 12.3.2 Amgen Description and Business Overview 12.3.3 Amgen Sales, Revenue and Gross Margin (2015-2020) 12.3.4 Amgen C-MET / HGF Inhibitors Products Offered 12.3.5 Amgen Recent Development 12.4 ArQule 12.4.1 ArQule Corporation Information 12.4.2 ArQule Description and Business Overview 12.4.3 ArQule Sales, Revenue and Gross Margin (2015-2020) 12.4.4 ArQule C-MET / HGF Inhibitors Products Offered 12.4.5 ArQule Recent Development 12.5 Astex Therapeutics 12.5.1 Astex Therapeutics Corporation Information 12.5.2 Astex Therapeutics Description and Business Overview 12.5.3 Astex Therapeutics Sales, Revenue and Gross Margin (2015-2020) 12.5.4 Astex Therapeutics C-MET / HGF Inhibitors Products Offered 12.5.5 Astex Therapeutics Recent Development 12.6 AVEO Pharmaceuticals 12.6.1 AVEO Pharmaceuticals Corporation Information 12.6.2 AVEO Pharmaceuticals Description and Business Overview 12.6.3 AVEO Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020) 12.6.4 AVEO Pharmaceuticals C-MET / HGF Inhibitors Products Offered 12.6.5 AVEO Pharmaceuticals Recent Development 12.7 Bristol-Myers Squibb(BMS) 12.7.1 Bristol-Myers Squibb(BMS) Corporation Information 12.7.2 Bristol-Myers Squibb(BMS) Description and Business Overview 12.7.3 Bristol-Myers Squibb(BMS) Sales, Revenue and Gross Margin (2015-2020) 12.7.4 Bristol-Myers Squibb(BMS) C-MET / HGF Inhibitors Products Offered 12.7.5 Bristol-Myers Squibb(BMS) Recent Development 12.8 Chroma Therapeutics 12.8.1 Chroma Therapeutics Corporation Information 12.8.2 Chroma Therapeutics Description and Business Overview 12.8.3 Chroma Therapeutics Sales, Revenue and Gross Margin (2015-2020) 12.8.4 Chroma Therapeutics C-MET / HGF Inhibitors Products Offered 12.8.5 Chroma Therapeutics Recent Development 12.9 Daiichi Sankyo 12.9.1 Daiichi Sankyo Corporation Information 12.9.2 Daiichi Sankyo Description and Business Overview 12.9.3 Daiichi Sankyo Sales, Revenue and Gross Margin (2015-2020) 12.9.4 Daiichi Sankyo C-MET / HGF Inhibitors Products Offered 12.9.5 Daiichi Sankyo Recent Development 12.10 Deciphera Pharmaceuticals 12.10.1 Deciphera Pharmaceuticals Corporation Information 12.10.2 Deciphera Pharmaceuticals Description and Business Overview 12.10.3 Deciphera Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020) 12.10.4 Deciphera Pharmaceuticals C-MET / HGF Inhibitors Products Offered 12.10.5 Deciphera Pharmaceuticals Recent Development 12.11 Abxign 12.11.1 Abxign Corporation Information 12.11.2 Abxign Description and Business Overview 12.11.3 Abxign Sales, Revenue and Gross Margin (2015-2020) 12.11.4 Abxign C-MET / HGF Inhibitors Products Offered 12.11.5 Abxign Recent Development 12.12 Eli Lilly 12.12.1 Eli Lilly Corporation Information 12.12.2 Eli Lilly Description and Business Overview 12.12.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020) 12.12.4 Eli Lilly Products Offered 12.12.5 Eli Lilly Recent Development 12.13 Exelixis 12.13.1 Exelixis Corporation Information 12.13.2 Exelixis Description and Business Overview 12.13.3 Exelixis Sales, Revenue and Gross Margin (2015-2020) 12.13.4 Exelixis Products Offered 12.13.5 Exelixis Recent Development 12.14 Genmab 12.14.1 Genmab Corporation Information 12.14.2 Genmab Description and Business Overview 12.14.3 Genmab Sales, Revenue and Gross Margin (2015-2020) 12.14.4 Genmab Products Offered 12.14.5 Genmab Recent Development 12.15 Galaxy Biotech 12.15.1 Galaxy Biotech Corporation Information 12.15.2 Galaxy Biotech Description and Business Overview 12.15.3 Galaxy Biotech Sales, Revenue and Gross Margin (2015-2020) 12.15.4 Galaxy Biotech Products Offered 12.15.5 Galaxy Biotech Recent Development 12.16 GlaxoSmithKline(GSK) 12.16.1 GlaxoSmithKline(GSK) Corporation Information 12.16.2 GlaxoSmithKline(GSK) Description and Business Overview 12.16.3 GlaxoSmithKline(GSK) Sales, Revenue and Gross Margin (2015-2020) 12.16.4 GlaxoSmithKline(GSK) Products Offered 12.16.5 GlaxoSmithKline(GSK) Recent Development 12.17 Hutchison MediPharma 12.17.1 Hutchison MediPharma Corporation Information 12.17.2 Hutchison MediPharma Description and Business Overview 12.17.3 Hutchison MediPharma Sales, Revenue and Gross Margin (2015-2020) 12.17.4 Hutchison MediPharma Products Offered 12.17.5 Hutchison MediPharma Recent Development 12.18 Johnson & Johnson 12.18.1 Johnson & Johnson Corporation Information 12.18.2 Johnson & Johnson Description and Business Overview 12.18.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020) 12.18.4 Johnson & Johnson Products Offered 12.18.5 Johnson & Johnson Recent Development 12.19 Kringle Pharmaceuticals 12.19.1 Kringle Pharmaceuticals Corporation Information 12.19.2 Kringle Pharmaceuticals Description and Business Overview 12.19.3 Kringle Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020) 12.19.4 Kringle Pharmaceuticals Products Offered 12.19.5 Kringle Pharmaceuticals Recent Development 12.20 Merck 12.20.1 Merck Corporation Information 12.20.2 Merck Description and Business Overview 12.20.3 Merck Sales, Revenue and Gross Margin (2015-2020) 12.20.4 Merck Products Offered 12.20.5 Merck Recent Development 12.21 Methylgene 12.21.1 Methylgene Corporation Information 12.21.2 Methylgene Description and Business Overview 12.21.3 Methylgene Sales, Revenue and Gross Margin (2015-2020) 12.21.4 Methylgene Products Offered 12.21.5 Methylgene Recent Development 12.22 Novartis 12.22.1 Novartis Corporation Information 12.22.2 Novartis Description and Business Overview 12.22.3 Novartis Sales, Revenue and Gross Margin (2015-2020) 12.22.4 Novartis Products Offered 12.22.5 Novartis Recent Development 12.23 Pfizer 12.23.1 Pfizer Corporation Information 12.23.2 Pfizer Description and Business Overview 12.23.3 Pfizer Sales, Revenue and Gross Margin (2015-2020) 12.23.4 Pfizer Products Offered 12.23.5 Pfizer Recent Development 12.24 ProMetic BioTherapeutics 12.24.1 ProMetic BioTherapeutics Corporation Information 12.24.2 ProMetic BioTherapeutics Description and Business Overview 12.24.3 ProMetic BioTherapeutics Sales, Revenue and Gross Margin (2015-2020) 12.24.4 ProMetic BioTherapeutics Products Offered 12.24.5 ProMetic BioTherapeutics Recent Development 12.25 Takeda Pharmaceutical 12.25.1 Takeda Pharmaceutical Corporation Information 12.25.2 Takeda Pharmaceutical Description and Business Overview 12.25.3 Takeda Pharmaceutical Sales, Revenue and Gross Margin (2015-2020) 12.25.4 Takeda Pharmaceutical Products Offered 12.25.5 Takeda Pharmaceutical Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Porter’s Five Forces Analysis 13.5 Primary Interviews with Key C-MET / HGF Inhibitors Players (Opinion Leaders) 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 C-MET / HGF Inhibitors Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. C-MET / HGF Inhibitors Market Segments Table 2. Ranking of Global Top C-MET / HGF Inhibitors Manufacturers by Revenue (US$ Million) in 2019 Table 3. Global C-MET / HGF Inhibitors Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million) Table 4. Major Manufacturers of C-Met Biologic Inhibitors Table 5. Major Manufacturers of Small Molecule C-Met Inhibitors Table 6. Major Manufacturers of HGF Antagonist Antibodies Table 7. Major Manufacturers of C-Met Antagonist Antibodies(MetMAb) Table 8. Major Manufacturers of HGF Kringle Variant Antagonists Table 9. Global C-MET / HGF Inhibitors Market Size Growth Rate by Application 2020-2026 (K MT) Table 10. Global C-MET / HGF Inhibitors Market Size by Region (K MT) & (US$ Million): 2020 VS 2026 Table 11. Global C-MET / HGF Inhibitors Sales by Regions 2015-2020 (K MT) Table 12. Global C-MET / HGF Inhibitors Sales Market Share by Regions (2015-2020) Table 13. Global C-MET / HGF Inhibitors Revenue by Regions 2015-2020 (US$ Million) Table 14. Global C-MET / HGF Inhibitors Sales Forecast by Region (2021-2026) (K MT) Table 15. Global C-MET / HGF Inhibitors Sales by Manufacturers (2015-2020) (K MT) Table 16. Global C-MET / HGF Inhibitors Sales Share by Manufacturers (2015-2020) Table 17. Global C-MET / HGF Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020) Table 18. Global C-MET / HGF Inhibitors by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in C-MET / HGF Inhibitors as of 2019) Table 19. C-MET / HGF Inhibitors Revenue by Manufacturers (2015-2020) (US$ Million) Table 20. C-MET / HGF Inhibitors Revenue Share by Manufacturers (2015-2020) Table 21. Key Manufacturers C-MET / HGF Inhibitors Price (2015-2020) (USD/MT) Table 22. C-MET / HGF Inhibitors Manufacturers Manufacturing Base Distribution and Headquarters Table 23. Manufacturers C-MET / HGF Inhibitors Product Type Table 24. Date of International Manufacturers Enter into C-MET / HGF Inhibitors Market Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans Table 26. Global C-MET / HGF Inhibitors Sales by Type (2015-2020) (K MT) Table 27. Global C-MET / HGF Inhibitors Sales Share by Type (2015-2020) Table 28. Global C-MET / HGF Inhibitors Revenue by Type (2015-2020) (US$ Million) Table 29. Global C-MET / HGF Inhibitors Revenue Share by Type (2015-2020) Table 30. C-MET / HGF Inhibitors Average Selling Price (ASP) by Type 2015-2020 (USD/MT) Table 31. Global C-MET / HGF Inhibitors Sales Share by Type (2021-2026) Table 32. Global C-MET / HGF Inhibitors Sales by Application (2015-2020) (K MT) Table 33. Global C-MET / HGF Inhibitors Sales Share by Application (2015-2020) Table 34. Global C-MET / HGF Inhibitors Sales Share by Application (2021-2026) Table 35. Global C-MET / HGF Inhibitors Sales Market Share Forecast by Application (2021-2026) Table 36. Global C-MET / HGF Inhibitors Revenue by Application (2015-2020) (US$ Million) Table 37. Global C-MET / HGF Inhibitors Revenue Market Share Forecast by Application (2021-2026) Table 38. United States C-MET / HGF Inhibitors Sales (K MT) of Key Companies (2015-2020) Table 39. United States C-MET / HGF Inhibitors Sales Share by Company (2015-2020) Table 40. United States C-MET / HGF Inhibitors Revenue (US$ Million) by Company (2015-2020) Table 41. United States C-MET / HGF Inhibitors Sales (K MT) by Type (2015-2020) Table 42. United States C-MET / HGF Inhibitors Sales Share by Type (2015-2020) Table 43. United States C-MET / HGF Inhibitors Revenue (US$ Million) Market Share by Type (2015-2020) Table 44. United States C-MET / HGF Inhibitors Price (K MT) by Type (2015-2020) Table 45. United States C-MET / HGF Inhibitors Sales (K MT) by Type (2021-2026) Table 46. United States C-MET / HGF Inhibitors Sales Share by Type (2021-2026) Table 47. United States C-MET / HGF Inhibitors Revenue (US$ Million) Market Share by Type (2021-2026) Table 48. United States C-MET / HGF Inhibitors Revenue Share by Type (2021-2026) Table 49. United States C-MET / HGF Inhibitors Price (K MT) by Type (2021-2026) Table 50. United States C-MET / HGF Inhibitors Sales (K MT) by Application (2015-2020) Table 51. United States C-MET / HGF Inhibitors Sales Share by Application (2015-2020) Table 52. United States C-MET / HGF Inhibitors Revenue (US$ Million) Market Share by Application (2015-2020) Table 53. United States C-MET / HGF Inhibitors Sales (K MT) by Application (2021-2026) Table 54. United States C-MET / HGF Inhibitors Sales Share by Application (2021-2026) Table 55. United States C-MET / HGF Inhibitors Revenue (US$ Million) Market Share by Application (2021-2026) Table 56. United States C-MET / HGF Inhibitors Revenue Share by Application (2021-2026) Table 57. North America C-MET / HGF Inhibitors Sales by Country (2015-2020) (K MT) Table 58. North America C-MET / HGF Inhibitors Sales Market Share by Country (2015-2020) Table 59. North America C-MET / HGF Inhibitors Revenue by Country (2015-2020) (US$ Million) Table 60. North America C-MET / HGF Inhibitors Revenue Market Share by Country (2015-2020) Table 61. Europe C-MET / HGF Inhibitors Sales by Country (2015-2020) (K MT) Table 62. Europe C-MET / HGF Inhibitors Sales Market Share by Country (2015-2020) Table 63. Europe C-MET / HGF Inhibitors Revenue by Country (2015-2020) (US$ Million) Table 64. Europe C-MET / HGF Inhibitors Revenue Market Share by Country (2015-2020) Table 65. Asia Pacific C-MET / HGF Inhibitors Sales by Region (2015-2020) (K MT) Table 66. Asia Pacific C-MET / HGF Inhibitors Sales Market Share by Region (2015-2020) Table 67. Asia Pacific C-MET / HGF Inhibitors Revenue by Region (2015-2020) (US$ Million) Table 68. Asia Pacific C-MET / HGF Inhibitors Revenue Market Share by Region (2015-2020) Table 69. Latin America C-MET / HGF Inhibitors Sales by Country (2015-2020) (K MT) Table 70. Latin America C-MET / HGF Inhibitors Sales Market Share by Country (2015-2020) Table 71. Latin Americaa C-MET / HGF Inhibitors Revenue by Country (2015-2020) (US$ Million) Table 72. Latin America C-MET / HGF Inhibitors Revenue Market Share by Country (2015-2020) Table 73. Middle East and Africa C-MET / HGF Inhibitors Sales by Country (2015-2020) (K MT) Table 74. Middle East and Africa C-MET / HGF Inhibitors Sales Market Share by Country (2015-2020) Table 75. Middle East and Africa C-MET / HGF Inhibitors Revenue by Country (2015-2020) (US$ Million) Table 76. Middle East and Africa C-MET / HGF Inhibitors Revenue Market Share by Country (2015-2020) Table 77. Abxign Corporation Information Table 78. Abxign Description and Business Overview Table 79. Abxign C-MET / HGF Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 80. Abxign C-MET / HGF Inhibitors Product Table 81. Abxign Recent Development Table 82. Abbott Laboratories Corporation Information Table 83. Abbott Laboratories Description and Business Overview Table 84. Abbott Laboratories C-MET / HGF Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 85. Abbott Laboratories Product Table 86. Abbott Laboratories Recent Development Table 87. Amgen Corporation Information Table 88. Amgen Description and Business Overview Table 89. Amgen C-MET / HGF Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 90. Amgen Product Table 91. Amgen Recent Development Table 92. ArQule Corporation Information Table 93. ArQule Description and Business Overview Table 94. ArQule C-MET / HGF Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 95. ArQule Product Table 96. ArQule Recent Development Table 97. Astex Therapeutics Corporation Information Table 98. Astex Therapeutics Description and Business Overview Table 99. Astex Therapeutics C-MET / HGF Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 100. Astex Therapeutics Product Table 101. Astex Therapeutics Recent Development Table 102. AVEO Pharmaceuticals Corporation Information Table 103. AVEO Pharmaceuticals Description and Business Overview Table 104. AVEO Pharmaceuticals C-MET / HGF Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 105. AVEO Pharmaceuticals Product Table 106. AVEO Pharmaceuticals Recent Development Table 107. Bristol-Myers Squibb(BMS) Corporation Information Table 108. Bristol-Myers Squibb(BMS) Description and Business Overview Table 109. Bristol-Myers Squibb(BMS) C-MET / HGF Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 110. Bristol-Myers Squibb(BMS) Product Table 111. Bristol-Myers Squibb(BMS) Recent Development Table 112. Chroma Therapeutics Corporation Information Table 113. Chroma Therapeutics Description and Business Overview Table 114. Chroma Therapeutics C-MET / HGF Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 115. Chroma Therapeutics Product Table 116. Chroma Therapeutics Recent Development Table 117. Daiichi Sankyo Corporation Information Table 118. Daiichi Sankyo Description and Business Overview Table 119. Daiichi Sankyo C-MET / HGF Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 120. Daiichi Sankyo Product Table 121. Daiichi Sankyo Recent Development Table 122. Deciphera Pharmaceuticals Corporation Information Table 123. Deciphera Pharmaceuticals Description and Business Overview Table 124. Deciphera Pharmaceuticals C-MET / HGF Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 125. Deciphera Pharmaceuticals Product Table 126. Deciphera Pharmaceuticals Recent Development Table 127. Eisai Corporation Information Table 128. Eisai Description and Business Overview Table 129. Eisai C-MET / HGF Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 130. Eisai Product Table 131. Eisai Recent Development Table 132. Eli Lilly Corporation Information Table 133. Eli Lilly Description and Business Overview Table 134. Eli Lilly C-MET / HGF Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 135. Eli Lilly Product Table 136. Eli Lilly Recent Development Table 137. Exelixis Corporation Information Table 138. Exelixis Description and Business Overview Table 139. Exelixis C-MET / HGF Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 140. Exelixis Product Table 141. Exelixis Recent Development Table 142. Genmab Corporation Information Table 143. Genmab Description and Business Overview Table 144. Genmab C-MET / HGF Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 145. Genmab Product Table 146. Genmab Recent Development Table 147. Galaxy Biotech Corporation Information Table 148. Galaxy Biotech Description and Business Overview Table 149. Galaxy Biotech C-MET / HGF Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 150. Galaxy Biotech Product Table 151. Galaxy Biotech Recent Development Table 152. GlaxoSmithKline(GSK) Corporation Information Table 153. GlaxoSmithKline(GSK) Description and Business Overview Table 154. GlaxoSmithKline(GSK) C-MET / HGF Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 155. GlaxoSmithKline(GSK) Product Table 156. GlaxoSmithKline(GSK) Recent Development Table 157. Hutchison MediPharma Corporation Information Table 158. Hutchison MediPharma Description and Business Overview Table 159. Hutchison MediPharma C-MET / HGF Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 160. Hutchison MediPharma Product Table 161. Hutchison MediPharma Recent Development Table 162. Johnson & Johnson Corporation Information Table 163. Johnson & Johnson Description and Business Overview Table 164. Johnson & Johnson C-MET / HGF Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 165. Johnson & Johnson Product Table 166. Johnson & Johnson Recent Development Table 167. Kringle Pharmaceuticals Corporation Information Table 168. Kringle Pharmaceuticals Description and Business Overview Table 169. Kringle Pharmaceuticals C-MET / HGF Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 170. Kringle Pharmaceuticals Product Table 171. Kringle Pharmaceuticals Recent Development Table 172. Merck Corporation Information Table 173. Merck Description and Business Overview Table 174. Merck C-MET / HGF Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 175. Merck Product Table 176. Merck Recent Development Table 177. Methylgene Corporation Information Table 178. Methylgene Description and Business Overview Table 179. Methylgene C-MET / HGF Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 180. Methylgene Product Table 181. Methylgene Recent Development Table 182. Novartis Corporation Information Table 183. Novartis Description and Business Overview Table 184. Novartis C-MET / HGF Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 185. Novartis Product Table 186. Novartis Recent Development Table 187. Pfizer Corporation Information Table 188. Pfizer Description and Business Overview Table 189. Pfizer C-MET / HGF Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 190. Pfizer Product Table 191. Pfizer Recent Development Table 192. ProMetic BioTherapeutics Corporation Information Table 193. ProMetic BioTherapeutics Description and Business Overview Table 194. ProMetic BioTherapeutics C-MET / HGF Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 195. ProMetic BioTherapeutics Product Table 196. ProMetic BioTherapeutics Recent Development Table 197. Takeda Pharmaceutical Corporation Information Table 198. Takeda Pharmaceutical Description and Business Overview Table 199. Takeda Pharmaceutical C-MET / HGF Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 200. Takeda Pharmaceutical Product Table 201. Takeda Pharmaceutical Recent Development Table 202. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 203. Key Challenges Table 204. Market Risks Table 205. Main Points Interviewed from Key C-MET / HGF Inhibitors Players Table 206. C-MET / HGF Inhibitors Customers List Table 207. C-MET / HGF Inhibitors Distributors List Table 208. Research Programs/Design for This Report Table 209. Key Data Information from Secondary Sources Table 210. Key Data Information from Primary Sources List of Figures Figure 1. C-MET / HGF Inhibitors Product Picture Figure 2. Global C-MET / HGF Inhibitors Sales Market Share by Type in 2020 & 2026 Figure 3. C-Met Biologic Inhibitors Product Picture Figure 4. Small Molecule C-Met Inhibitors Product Picture Figure 5. HGF Antagonist Antibodies Product Picture Figure 6. C-Met Antagonist Antibodies(MetMAb) Product Picture Figure 7. HGF Kringle Variant Antagonists Product Picture Figure 8. Global C-MET / HGF Inhibitors Sales Market Share by Application in 2020 & 2026 Figure 9. Hospital Pharmacies Figure 10. Retail Pharmacies Figure 11. Drug Stores Figure 12. Online Sales Figure 13. C-MET / HGF Inhibitors Report Years Considered Figure 14. Global C-MET / HGF Inhibitors Market Size 2015-2026 (US$ Million) Figure 15. Global C-MET / HGF Inhibitors Sales 2015-2026 (K MT) Figure 16. Global C-MET / HGF Inhibitors Market Size Market Share by Region: 2020 Versus 2026 Figure 17. Global C-MET / HGF Inhibitors Sales Market Share by Region (2015-2020) Figure 18. Global C-MET / HGF Inhibitors Sales Market Share by Region in 2019 Figure 19. Global C-MET / HGF Inhibitors Revenue Market Share by Region (2015-2020) Figure 20. Global C-MET / HGF Inhibitors Revenue Market Share by Region in 2019 Figure 21. Global C-MET / HGF Inhibitors Sales Share by Manufacturer in 2019 Figure 22. The Top 10 and 5 Players Market Share by C-MET / HGF Inhibitors Revenue in 2019 Figure 23. C-MET / HGF Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 24. Global C-MET / HGF Inhibitors Sales Market Share by Type (2015-2020) Figure 25. Global C-MET / HGF Inhibitors Sales Market Share by Type in 2019 Figure 26. Global C-MET / HGF Inhibitors Revenue Market Share by Type (2015-2020) Figure 27. Global C-MET / HGF Inhibitors Revenue Market Share by Type in 2019 Figure 28. Global C-MET / HGF Inhibitors Market Share by Price Range (2015-2020) Figure 29. Global C-MET / HGF Inhibitors Sales Market Share by Application (2015-2020) Figure 30. Global C-MET / HGF Inhibitors Sales Market Share by Application in 2019 Figure 31. Global C-MET / HGF Inhibitors Revenue Market Share by Application (2015-2020) Figure 32. Global C-MET / HGF Inhibitors Revenue Market Share by Application in 2019 Figure 33. United States C-MET / HGF Inhibitors Sales Growth Rate 2015-2026 (K MT) Figure 34. United States C-MET / HGF Inhibitors Revenue Growth Rate 2015-2026 (US$ Million) Figure 35. United States C-MET / HGF Inhibitors Market Share in Global Market 2015-2026 Figure 36. United States 5 and 10 Largest C-MET / HGF Inhibitors Players Market Share by Revenue in C-MET / HGF Inhibitors in 2019 Figure 37. United States C-MET / HGF Inhibitors Revenue Share by Type (2015-2020) Figure 38. United States C-MET / HGF Inhibitors Revenue Growth Rate by Type in 2015 & 2019 Figure 39. United States C-MET / HGF Inhibitors Revenue Share by Application (2015-2020) Figure 40. United States C-MET / HGF Inhibitors Revenue Growth Rate by Application in 2015 & 2019 Figure 41. North America C-MET / HGF Inhibitors Sales Growth Rate 2015-2020 (K MT) Figure 42. North America C-MET / HGF Inhibitors Revenue Growth Rate 2015-2020 (US$ Million) Figure 43. North America C-MET / HGF Inhibitors Sales Market Share by Country in 2019 Figure 44. North America C-MET / HGF Inhibitors Revenue Market Share by Country in 2019 Figure 45. U.S. C-MET / HGF Inhibitors Sales Growth Rate (2015-2020) (K MT) Figure 46. U.S. C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. Canada C-MET / HGF Inhibitors Sales Growth Rate (2015-2020) (K MT) Figure 48. Canada C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. Europe C-MET / HGF Inhibitors Sales Growth Rate 2015-2020 (K MT) Figure 50. Europe C-MET / HGF Inhibitors Revenue Growth Rate 2015-2020 (US$ Million) Figure 51. Europe C-MET / HGF Inhibitors Sales Market Share by Country in 2019 Figure 52. Europe C-MET / HGF Inhibitors Revenue Market Share by Country in 2019 Figure 53. Germany C-MET / HGF Inhibitors Sales Growth Rate (2015-2020) (K MT) Figure 54. Germany C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. France C-MET / HGF Inhibitors Sales Growth Rate (2015-2020) (K MT) Figure 56. France C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. U.K. C-MET / HGF Inhibitors Sales Growth Rate (2015-2020) (K MT) Figure 58. U.K. C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Italy C-MET / HGF Inhibitors Sales Growth Rate (2015-2020) (K MT) Figure 60. Italy C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Russia C-MET / HGF Inhibitors Sales Growth Rate (2015-2020) (K MT) Figure 62. Russia C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) (US$ Million) Figure 63. Asia Pacific C-MET / HGF Inhibitors Sales Growth Rate 2015-2020 (K MT) Figure 64. Asia Pacific C-MET / HGF Inhibitors Revenue Growth Rate 2015-2020 (US$ Million) Figure 65. Asia Pacific C-MET / HGF Inhibitors Sales Market Share by Region in 2019 Figure 66. Asia Pacific C-MET / HGF Inhibitors Revenue Market Share by Region in 2019 Figure 67. China C-MET / HGF Inhibitors Sales Growth Rate (2015-2020) (K MT) Figure 68. China C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Japan C-MET / HGF Inhibitors Sales Growth Rate (2015-2020) (K MT) Figure 70. Japan C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) (US$ Million) Figure 71. South Korea C-MET / HGF Inhibitors Sales Growth Rate (2015-2020) (K MT) Figure 72. South Korea C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. India C-MET / HGF Inhibitors Sales Growth Rate (2015-2020) (K MT) Figure 74. India C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. Australia C-MET / HGF Inhibitors Sales Growth Rate (2015-2020) (K MT) Figure 76. Australia C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. Taiwan C-MET / HGF Inhibitors Sales Growth Rate (2015-2020) (K MT) Figure 78. Taiwan C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) (US$ Million) Figure 79. Indonesia C-MET / HGF Inhibitors Sales Growth Rate (2015-2020) (K MT) Figure 80. Indonesia C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) (US$ Million) Figure 81. Thailand C-MET / HGF Inhibitors Sales Growth Rate (2015-2020) (K MT) Figure 82. Thailand C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) (US$ Million) Figure 83. Malaysia C-MET / HGF Inhibitors Sales Growth Rate (2015-2020) (K MT) Figure 84. Malaysia C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) (US$ Million) Figure 85. Philippines C-MET / HGF Inhibitors Sales Growth Rate (2015-2020) (K MT) Figure 86. Philippines C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) (US$ Million) Figure 87. Vietnam C-MET / HGF Inhibitors Sales Growth Rate (2015-2020) (K MT) Figure 88. Vietnam C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) (US$ Million) Figure 89. Latin America C-MET / HGF Inhibitors Sales Growth Rate 2015-2020 (K MT) Figure 90. Latin America C-MET / HGF Inhibitors Revenue Growth Rate 2015-2020 (US$ Million) Figure 91. Latin America C-MET / HGF Inhibitors Sales Market Share by Country in 2019 Figure 92. Latin America C-MET / HGF Inhibitors Revenue Market Share by Country in 2019 Figure 93. Mexico C-MET / HGF Inhibitors Sales Growth Rate (2015-2020) (K MT) Figure 94. Mexico C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) (US$ Million) Figure 95. Brazil C-MET / HGF Inhibitors Sales Growth Rate (2015-2020) (K MT) Figure 96. Brazil C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) (US$ Million) Figure 97. Argentina C-MET / HGF Inhibitors Sales Growth Rate (2015-2020) (K MT) Figure 98. Argentina C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) (US$ Million) Figure 99. Middle East and Africa C-MET / HGF Inhibitors Sales Growth Rate 2015-2020 (K MT) Figure 100. Middle East and Africa C-MET / HGF Inhibitors Revenue Growth Rate 2015-2020 (US$ Million) Figure 101. Middle East and Africa C-MET / HGF Inhibitors Sales Market Share by Country in 2019 Figure 102. Middle East and Africa C-MET / HGF Inhibitors Revenue Market Share by Country in 2019 Figure 103. Turkey C-MET / HGF Inhibitors Sales Growth Rate (2015-2020) (K MT) Figure 104. Turkey C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) (US$ Million) Figure 105. Saudi Arabia C-MET / HGF Inhibitors Sales Growth Rate (2015-2020) (K MT) Figure 106. Saudi Arabia C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) (US$ Million) Figure 107. U.A.E C-MET / HGF Inhibitors Sales Growth Rate (2015-2020) (K MT) Figure 108. U.A.E C-MET / HGF Inhibitors Revenue Growth Rate (2015-2020) (US$ Million) Figure 109. Porter's Five Forces Analysis Figure 110. C-MET / HGF Inhibitors Value Chain Figure 111. Channels of Distribution Figure 112. Distributors Profiles Figure 113. Bottom-up and Top-down Approaches for This Report Figure 114. Data Triangulation Figure 115. Key Executives Interviewed

Abxign Abbott Laboratories Amgen ArQule Astex Therapeutics AVEO Pharmaceuticals Bristol-Myers Squibb(BMS) Chroma Therapeutics Daiichi Sankyo Deciphera Pharmaceuticals Eisai Eli Lilly Exelixis Genmab Galaxy Biotech GlaxoSmithKline(GSK) Hutchison MediPharma Johnson & Johnson Kringle Pharmaceuticals Merck Methylgene Novartis Pfizer ProMetic BioTherapeutics Takeda Pharmaceutical